These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 403037)

  • 41. A case of GM1-gangliosidosis type I: glycosphingolipid profiles of urine and transformed lymphocytes and beta-D-galactosidase activities in peripheral lymphocytes, cultured skin fibroblasts and transformed lymphocytes.
    Asano K; Shindo N; Nakasuji M; Inamori K; Ohta M; Matsushita T; Yamaguchi M; Oshima M
    Jpn J Exp Med; 1990 Apr; 60(2):73-9. PubMed ID: 2117086
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Prenatal enzymatic diagnosis of Krabbe disease (globoid-cell leukodystrophy) using chorionic villi. Pitfalls in the use of uncultured villi.
    Harzer K; Schuster I
    Hum Genet; 1989 Dec; 84(1):83-5. PubMed ID: 2606482
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Hematopoietic cell transplantation in murine globoid cell leukodystrophy (the twitcher mouse): effects on levels of galactosylceramidase, psychosine, and galactocerebrosides.
    Ichioka T; Kishimoto Y; Brennan S; Santos GW; Yeager AM
    Proc Natl Acad Sci U S A; 1987 Jun; 84(12):4259-63. PubMed ID: 2884662
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Spectrophotometric and fluorimetric assays of galactocerebrosidase activity, their use in the diagnosis of Krabbe's disease.
    Besley GT; Gatt S
    Clin Chim Acta; 1981 Feb; 110(1):19-26. PubMed ID: 7214711
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Incorporation and degradation of GM1 ganglioside and asialoGM1 ganglioside in cultured fibroblasts from normal individuals and patients with beta-galactosidase deficiency.
    Kobayashi T; Shinnoh N; Kuroiwa Y
    Biochim Biophys Acta; 1986 Jan; 875(1):115-21. PubMed ID: 3079639
    [TBL] [Abstract][Full Text] [Related]  

  • 46. An improved method for the identification of patients and carriers of Krabbe's disease.
    Wenger DA; Sattler M; Clark C; McKelvey H
    Clin Chim Acta; 1974 Oct; 56(2):199-206. PubMed ID: 4434632
    [No Abstract]   [Full Text] [Related]  

  • 47. Properties of a protein activator of glycosphingolipid hydrolysis isolated from the liver of a patient with GM1 gangliosidosis, type 1.
    Inui K; Wenger DA
    Biochem Biophys Res Commun; 1982 Mar; 105(2):745-51. PubMed ID: 6807306
    [No Abstract]   [Full Text] [Related]  

  • 48. Use of a chromogenic substrate for the diagnosis of Krabbe's disease, with special reference to its application in prenatal diagnosis.
    Besley GT; Bain AD
    Clin Chim Acta; 1978 Sep; 88(2):229-36. PubMed ID: 699319
    [TBL] [Abstract][Full Text] [Related]  

  • 49. A comparison of the properties and bile salt specificities of galactosylceramide and lactosyl ceramide beta-galactosidase activities in human leucocytes and fibroblasts.
    Poulos A; Beckman K
    Clin Chim Acta; 1980 Feb; 101(2-3):277-85. PubMed ID: 6766828
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Variability of acid hydrolase activities in cultured skin fibroblasts and amniotic fluid cells.
    Young E; Willcox P; Whitfield AE; Patrick AD
    J Med Genet; 1975 Sep; 12(3):224-9. PubMed ID: 809585
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The use of natural and artifical substrates in the prenatal diagnosis of Krabbe's disease.
    Besley GT
    J Inherit Metab Dis; 1978; 1(3):115-8. PubMed ID: 116080
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Use of a fluorogenic substrate, 6-hexadecanoylamino-4-methylumbelliferyl-beta-D-galactopyranoside, in the diagnosis of Krabbe disease.
    Grimm U; Zschiesche M; Widerschain G; Seidlitz G; Machill G
    J Inherit Metab Dis; 1991; 14(6):940-1. PubMed ID: 1779655
    [No Abstract]   [Full Text] [Related]  

  • 53. GM1-ganglioside and lactosylceramide beta-galactosidase from rabbit brain: inhibitor and substrate competition studies.
    Callahan JW; Gerrie J
    Can J Biochem; 1976 Sep; 54(9):803-12. PubMed ID: 971464
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Diagnosis of feline GM1 gangliosidosis by enzyme assay of cultured conjunctival cells.
    Nowakowski RW; Thompson JN; Baker HJ
    Invest Ophthalmol Vis Sci; 1988 Mar; 29(3):487-90. PubMed ID: 3125124
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Multiplicity of bovine liver GM1 ganglioside beta-galactosidase.
    Hiraiwa M; Shiraishi T; Uda Y
    J Biochem; 1986 Jul; 100(1):255-8. PubMed ID: 3093471
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Antenatal diagnosis of Krabbe's leucodystrophy: enzymatic and morphological confirmation in an affected fetus.
    Farrell DF; Sumi SM; Scott CR; Rice G
    J Neurol Neurosurg Psychiatry; 1978 Jan; 41(1):76-82. PubMed ID: 621534
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Lysosomal storage diseases.
    Glew RH; Basu A; Prence EM; Remaley AT
    Lab Invest; 1985 Sep; 53(3):250-69. PubMed ID: 2993742
    [No Abstract]   [Full Text] [Related]  

  • 58. [Lysosomal beta-galactosidase properties and the molecular genetics of GM1 gangliosidosis].
    Vel'tishchev IuE; Kalaidzhieva LV
    Vopr Med Khim; 1979; 25(6):709-15. PubMed ID: 117628
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Studies on galactosyl ceramide and lactosyl ceramide beta-galactosidase.
    Wenger DA
    Chem Phys Lipids; 1974 Dec; 13(4):327-9. PubMed ID: 4452215
    [No Abstract]   [Full Text] [Related]  

  • 60. [Biochemical variation in Gm1-gangliosidosis (author's transl)].
    Orii T
    Hokkaido Igaku Zasshi; 1978 Nov; 52(6):247-9. PubMed ID: 415956
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.